# Scaffolds and Stem Cells Show Promise for TMJ Regeneration: A Systematic Review

**Authors:** Miljana Nedeljkovic, Gvozden Rosic, Dragica Selakovic, Jovana Milanovic, Aleksandra Arnaut, Milica Vasiljevic, Nemanja Jovicic, Lidija Veljkovic, Pavle Milanovic, Momir Stevanovic

PMC · DOI: 10.3390/bioengineering13020169 · Bioengineering · 2026-01-29

## TL;DR

This review explores how scaffolds and stem cells could help regenerate the temporomandibular joint, but highlights the need for more consistent research methods.

## Contribution

The paper systematically reviews preclinical scaffold-based strategies for TMJ regeneration and identifies key challenges in study design and reporting.

## Key findings

- Natural scaffolds like collagen hydrogels support fibrocartilage regeneration, while synthetic materials offer better mechanical stability.
- Cellular and bioactive components enhance tissue regeneration, but study outcomes are inconsistent due to varied experimental designs.
- Standardized methodologies and long-term functional assessments are needed to improve translational potential.

## Abstract

Temporomandibular joint (TMJ) disorders represent chronic degenerative musculoskeletal conditions with a high prevalence in the general population and limited regenerative treatment options. Owing to the insufficient efficacy of current conservative and surgical therapies, there is a growing clinical need for biologically based regenerative approaches. Tissue engineering (TE), particularly scaffold-based strategies, has emerged as a promising avenue for TMJ regeneration. This systematic review analyzed preclinical in vivo studies investigating scaffold-based interventions for TMJ disc and osteochondral repair. A structured literature search of PubMed and Scopus databases identified 39 eligible studies. Extracted data included scaffold composition, use of cellular and bioactive components, animal models, and reported histological, radiological, and functional outcomes. Natural scaffolds, such as decellularized extracellular matrix and collagen-based hydrogels, demonstrated favorable biocompatibility and support for fibrocartilaginous regeneration, whereas synthetic materials including polycaprolactone, poly (lactic-co-glycolic acid), and polyvinyl alcohol provided superior mechanical stability and structural tunability. Cells were used in 17/39 studies (43%); quantitative improvements were variably reported across these studies. Bioactive molecule delivery, including transforming growth factor-β, histatin-1, and platelet-rich plasma, further enhanced tissue regeneration, while emerging drug- and gene-delivery approaches showed potential for modulating local inflammation. Despite encouraging results, the reviewed studies exhibited substantial heterogeneity in experimental design, outcome measures, and animal models, limiting direct comparison and translational interpretation. Scaffold-based approaches show preclinical promise but heterogeneity in design and incomplete quantitative reporting limit definitive conclusions. Future research should emphasize standardized methodologies, long-term functional evaluation, and the use of clinically relevant large-animal models to facilitate translation toward clinical application. However, functional and biomechanical outcomes were inconsistently reported and rarely standardized, preventing robust conclusions regarding the relationship between structural regeneration and restoration of TMJ function.

## Linked entities

- **Proteins:** HTN1 (histatin 1)

## Full-text entities

- **Genes:** NELL1 (neural EGFL like 1) [NCBI Gene 4745] {aka IDH3GL}, HTN1 (histatin 1) [NCBI Gene 3346] {aka HIS1, Hst1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, CCN2 (cellular communication network factor 2) [NCBI Gene 1490] {aka CTGF, HCS24, IBP-8, IGFBP8, KMD, NOV2}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}
- **Diseases:** muscle hyperactivity (MESH:D009135), disc perforation (MESH:D057112), chronic pain (MESH:D059350), disc (MESH:D055959), musculoskeletal conditions (MESH:D009140), Articular (MESH:D057072), osteolysis (MESH:D010014), TMJ (MESH:D013706), SYRCLE (MESH:D007757), TMDs (MESH:D013705), osteoarthritis (MESH:D010003), ectopic ossification (MESH:D009999), trismus (MESH:D014313), myofascial pain (MESH:D009209), impaired mastication (MESH:D060825), pain (MESH:D010146), inflammation (MESH:D007249), limitation of jaw motion (MESH:D007571), headaches (MESH:D006261), degenerative (MESH:D019636), injury to (MESH:D014947)
- **Chemicals:** PLGA (MESH:D000077182), lipid (MESH:D008055), PCL (MESH:C016240), PVA (MESH:D011142), naproxen (MESH:D009288), GelMA (-), PGS (MESH:D010715), poly(glycerol sebacate) (MESH:C469892), PEGDA (MESH:C437167)
- **Species:** Capra hircus (domestic goat, species) [taxon 9925], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Sus scrofa (pig, species) [taxon 9823], Ovis aries (domestic sheep, species) [taxon 9940], Canis lupus familiaris (dog, subspecies) [taxon 9615]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938102/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938102/full.md

## References

111 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938102/full.md

---
Source: https://tomesphere.com/paper/PMC12938102